help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hsu, J. H.
Right arrow Articles by Brent, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hsu, J. H.
Right arrow Articles by Brent, G. A.

Endocrinology, Vol 136, 421-430, Copyright © 1995 by Endocrine Society


ARTICLES

Retinoid-X receptor (RXR) differentially augments thyroid hormone response in cell lines as a function of the response element and endogenous RXR content

JH Hsu, AM Zavacki, JW Harney and GA Brent
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115.

Retinoid-X receptor (RXR) forms heterodimers with thyroid hormone receptor (TR) and significantly enhances binding to thyroid hormone response elements (TREs). Expression of RXR in a transient transfection assay augments the T3 response, but the influences of the specific cell line and TRE used have not been systematically studied. We determined RXR alpha and -beta augmentation of the TR alpha-mediated T3 response in transient transfection assays of COS, JEG, and mouse embryonic stem (ES) cell lines for a series of eight wild-type thyroid hormone (T3) and retinoic acid response elements (previously shown to bind TR). RXR augmented T3-induced expression in COS and ES cells (1.5- to 4-fold greater expression with added RXR compared to TR alone), but had minimal effect on augmentation of response in JEG cells. For most elements studied there was a proportional augmentation of basal and T3- stimulated expression. TREs from rat GH and laminin-B1, however, had relatively higher levels of T3-induced expression as a result of RXR cotransfection (T3 induction ratios increased 2-fold or greater). Previous characterization of these elements demonstrates that they contain more than two hexameric binding domains, all of which can simultaneously bind TR. The influence of endogenous RXR expression in a cell line on RXR augmentation of the T3 response was determined. RXR alpha and -beta messenger RNA (mRNA) expression was quantitated by Northern blot in each cell line. COS and JEG cells expressed almost exclusively RXR alpha mRNA, although expression was almost 2-fold higher in JEG compared to COS cells (12 +/- 2.5 vs. 6.8 +/- 0.5 density units relative to actin; mean +/- SE; P < 0.05). ES cells expressed only RXR beta mRNA, but at a very low level (0.4 +/- 0.1). Nuclear extracts prepared from JEG and COS cells augmented TR binding proportional to the endogenous RXR mRNA expression, and the heterodimer band was supershifted by the addition of antibody to RXR alpha. Nuclear extracts from ES cells had no detectable TR heterodimer binding to a range of response elements. RXR augmentation of the T3 response differs among cell lines and is greater in those with reduced endogenous RXR. Furthermore, the functional augmentation of the T3 response ratio by RXR is likely to require additional sequences contained in only a subset of elements in which RXR augments TR binding.


This article has been cited by other articles:


Home page
EndocrinologyHome page
M. Busson, L. Daury, P. Seyer, S. Grandemange, L. Pessemesse, F. Casas, C. Wrutniak-Cabello, and G. Cabello
Avian MyoD and c-Jun Coordinately Induce Transcriptional Activity of the 3,5,3'-Triiodothyronine Nuclear Receptor c-ErbA{alpha}1 in Proliferating Myoblasts
Endocrinology, July 1, 2006; 147(7): 3408 - 3418.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S.-W. Kim, S.-J. Hong, K. M. Kim, S.-C. Ho, E. C. So, J. W. Harney, and P. R. Larsen
A Novel Cell Type-Specific Mechanism for Thyroid Hormone-Dependent Negative Regulation of the Human Type 1 Deiodinase Gene
Mol. Endocrinol., December 1, 2004; 18(12): 2924 - 2936.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Q.-L. Li, E. Jansen, G. A. Brent, S. Naqvi, J. F. Wilber, and T. C. Friedman
Interactions between the Prohormone Convertase 2 Promoter and the Thyroid Hormone Receptor
Endocrinology, September 1, 2000; 141(9): 3256 - 3266.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Jeannin, D. Robyr, and B. Desvergne
Transcriptional Regulatory Patterns of the Myelin Basic Protein and Malic Enzyme Genes by the Thyroid Hormone Receptors alpha 1 and beta 1
J. Biol. Chem., September 11, 1998; 273(37): 24239 - 24248.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
K. A. O'Leary, H.-C. Li, P. A. Ram, P. McQuiddy, D. J. Waxman, and C. B. Kasper
Thyroid Regulation of NADPH:Cytochrome P450 Oxidoreductase: Identification of a Thyroid-Responsive Element in the 5'-Flank of the Oxidoreductase Gene
Mol. Pharmacol., July 1, 1997; 52(1): 46 - 53.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. P. Olson and R. J. Koenig
5'-Flanking Sequences in Thyroid Hormone Response Element Half-sites Determine the Requirement of Retinoid X Receptor for Receptor-mediated Gene Expression
J. Biol. Chem., April 11, 1997; 272(15): 9907 - 9914.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. J. Torrance, S. J. Usala, J. E. Pessin, and G. L. Dohm
Characterization of a Low Affinity Thyroid Hormone Receptor Binding Site within the Rat GLUT4 Gene Promoter
Endocrinology, March 1, 1997; 138(3): 1215 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. D. Safer, M. F. Langlois, R. Cohen, T. Monden, D. John-Hope, J. Madura, A. N. Hollenberg, and F. E. Wondisford
Isoform Variable Action among Thyroid Hormone Receptor Mutants Provides Insight into Pituitary Resistance to Thyroid Hormone
Mol. Endocrinol., January 1, 1997; 11(1): 16 - 26.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
W. S. Simonides, G. A. Brent, M. H.M. Thelen, C. G. van der Linden, P. R. Larsen, and C. van Hardeveld
Characterization of the Promoter of the Rat Sarcoplasmic Endoplasmic Reticulum Ca2+-ATPase 1Gene and Analysis of Thyroid Hormone Responsiveness
J. Biol. Chem., December 13, 1996; 271(50): 32048 - 32056.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. N. Hollenberg, T. Monden, J. P. Madura, K. Lee, and F. E. Wondisford
Function of Nuclear Co-repressor Protein on Thyroid Hormone Response Elements Is Regulated by the Receptor A/B Domain
J. Biol. Chem., November 8, 1996; 271(45): 28516 - 28520.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
O. Cohen, T. R. Flynn, and F. E. Wondisford
Ligand-dependent Antagonism by Retinoid X Receptors of Inhibitory Thyroid Hormone Response Elements
J. Biol. Chem., June 9, 1995; 270(23): 13899 - 13905.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wu, B. Xu, and R. J. Koenig
Thyroid Hormone Response Element Sequence and the Recruitment of Retinoid X Receptors for Thyroid Hormone Responsiveness
J. Biol. Chem., February 2, 2001; 276(6): 3929 - 3936.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society